Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.
HistoSonics announced that it has received approval in Europe for its Edison system, enabling the commercialization of the ...
FDA approves a 76-mm version of Abbott’s Esprit BTK resorbable scaffold system for patients with CLTI. The longer scaffold is intended to reduce the number of devices needed to treat long BTK lesions ...
Xeltis announced the official start of the European commercialization of aXess vascular access device for patients requiring hemod ...
The Society for Cardiovascular Angiography and Interventions (SCAI) announced that a multisociety expert consensus statement ...
Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announ ...
Vesalio announced the appointment of Greg Cook as Chief Commercial Officer, responsible for leading the company’s commercial ...
Stereotaxis announced that it has completed its previously announced acquisition of Robocath, a Rouen, France-based developer ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results